Format

Send to

Choose Destination
Otolaryngol Head Neck Surg. 2017 Jul;157(1):77-79. doi: 10.1177/0194599817703949. Epub 2017 May 2.

Treatment of Neurogenic Cough with Tramadol: A Pilot Study.

Author information

1
1 NYU Voice Center, Department of Otolaryngology-Head and Neck Surgery, New York University School of Medicine, New York, New York, USA.

Abstract

This study employs validated cough assessment tools to prospectively determine the impact of tramadol on cough severity and quality of life in subjects with neurogenic cough. The study was a prospective case series with planned data collection at a tertiary care academic medical center laryngology practice. Sixteen consecutive collected subjects with neurogenic cough prospectively completed pre- and posttreatment validated cough assessment tools, the cough severity index (CSI) and Leicester Cough Questionnaire (LCQ). All subjects in the study reported at least some improvement in their cough symptoms. In a Wilcoxon signed rank test that compared paired results, CSI scores improved from 23 to 14 and LCQ scores improved from 74 to 103 ( P = .003 and P = .005, respectively). This small preliminary assessment suggests that tramadol warrants additional evaluation as a treatment for neurogenic cough.

KEYWORDS:

cough; neurogenic cough; neurogenic cough treatment; neuropathic cough treatment; tramadol

PMID:
28463539
DOI:
10.1177/0194599817703949
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center